Botuobiotech released its half-year report for 2024, with revenue of 0.267 billion yuan in the first half of the year, a year-on-year increase of 25.97%; net income attributable to shareholders of listed companies was 72.1751 million yuan, a year-on-year increase of 17.16%.
博拓生物：上半年净利润7217.51万元 同比增长17.16%
Botuobiotech: Net income in the first half of the year was 72.1751 million yuan, a year-on-year increase of 17.16%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.